BSG and myocardial infarction: Concerning EMMPRIN, this molecule was object of study in atherosclerosis [34,35], cardiac fibrosis in a pressure overload murine model [36], scar tissue formation after myocardial infarction [37], inflammatory cardiomyopathy [10], and tissue remodeling [12,13], revealing its major activity in MMP and pro-fibrotic signaling activation.